Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting: 52-Week Data From the Phase 4 ARTISTYK Study. (2025). SKIN The Journal of Cutaneous Medicine, 9(6), s649. https://doi.org/10.25251/7j9e8h28